| Sr. No | Generic Name | Composition | Ph. Ref. | Strength |
|---|---|---|---|---|
| 1 | Ofloxacin Oral Suspension IP | Each 5ml Contains: – Ofloxacin In a flavoured base Approved colour used |
IP | 50 mg q.s. |
| 2 | Ofloxacin Oral Suspension IP | Each 5ml Contains: – Ofloxacin In a flavoured base Approved colour used |
IP | 100 mg q.s. |
| 3 | Paracetamol Oral Suspension IP | Each 5ml Contains: – Paracetamol In a flavoured base Approved colour used |
IP | 500 mg q.s. |
| 4 | Paracetamol Paediatric Oral Suspension IP | Each 5ml Contains: – Paracetamol In a flavoured base Approved colour used |
IP | 125 mg q.s. |
| 5 | Paracetamol Paediatric Oral Suspension IP | Each 5ml Contains: – Paracetamol In a flavoured base Approved colour used |
IP | 250 mg q.s. |
| 6 | Paracetamol Paediatric Syrup IP | Each 5ml Contains: – Paracetamol In a flavoured syrupy base Approved colour used |
IP | 125 mg q.s. |
| 7 | Azithromycin Oral Suspension IP | Each 5ml Contains: – Azithromycin Dihydrate Eq. to Anhydrous Azithromycin In a flavoured Syrupy base Approved colour used |
IP |
40 mg |
| 8 | Azithromycin Oral Suspension IP | Each 5ml Contains: – Azithromycin Dihydrate Eq. to Anhydrous Azithromycin In a flavoured Syrupy base Approved colour used |
IP |
50 mg |
| 9 | Azithromycin Oral Suspension IP | Each 5ml Contains: – Azithromycin Dihydrate Eq. to Anhydrous Azithromycin In a flavoured Syrupy base Approved colour used |
IP |
200 mg |
| 10 | Albendazole Oral Suspension IP | Each 5ml Contains: – Albendazole In a flavoured Syrupy base Approved colour used |
IP | 200 mg q.s. |
| 11 | Cetirizine Hydrochloride Syrup IP | Each 5ml Contains: – Cetirizine Hydrochloride In a flavoured Syrupy base Approved colour used |
IP | 5 mg |
| 12 | Luliconazole Cream IP | Composition: – Luliconazole Perservative Benzyl Alcohol Cream base |
IP |
1%w/w
1%w/w |
| 13 | Povidone Iodine Ointment USP | Composition: – Povidone Iodine Excipients |
IP | 5%w/w q.s. |
| 14 | Mometasone Furoate Cream IP | Each g Contains: – Mometasone Furoate In a cream base Excipients |
IP | 0.1%w/w q.s. |
| 15 | Mupirocin Ointment IP | Composition: – Mupirocin Topical Ointment Base |
IP | 2.0%w/w q.s. |
| 16 | Mometasone Furoate & Fusidic Acid Cream IP | Composition: – Mometasone furoate Fusidic Acid Cream base |
IP IP |
0.1%w/w 2%w/w q.s. |
| 17 | Torsemide Tablets IP | Each uncoated tablet contain: Torsemide Excipients Approved colour used |
IP | 5 mg q.s. |
| 18 | Torsemide Tablets IP | Each uncoated tablet contain: Torsemide Excipients Approved colour used |
IP | 10 mg q.s. |
| 19 | Torsemide Tablets IP | Each uncoated tablet contain: Torsemide Excipients Approved colour used |
IP | 20 mg q.s. |
| 20 | Torsemide Tablets IP | Each uncoated tablet contain: Torsemide Excipients Approved colour used |
IP | 100 mg q.s. |
| 21 | Tadalafil Tablet IP | Each film coated tablet contain: Tadalafil Excipients Approved colour used |
IP | 20 mg q.s. |
| 22 | Metformin Hydrochloride (Prolong Release) and Glimepiride Tablets IP | Each uncoated bilayerd tablet contains: Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Approved Colour Used |
IP IP |
500 mg
1mg |
| 23 | Metformin Hydrochloride (Prolong Release) and Glimepiride Tablest IP | Each uncoated bilayerd tablet contains: Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Approved Colour Used |
IP IP |
500 mg
2mg |
| 24 | Rosuvastatin Tablets IP | Each film coated tablet contains: Rosuvastatin Calcium Equivalent to Rosuvastatin Excipients Approved Colour Used |
IP |
5 mg |
| 25 | Rosuvastatin Tablets IP | Each film coated tablet contains: Rosuvastatin Calcium Equivalent to Rosuvastatin Excipients Approved Colour Used |
IP |
10 mg |
| 26 | Rosuvastatin Tablets IP | Each film coated tablet contains: Rosuvastatin Calcium Equivalent to Rosuvastatin Excipients Approved Colour Used |
IP |
20 mg |
| 27 | Glimepiride Tablets IP | Each uncoated tablet contains: Glimepiride Excipients Approved Colour Used |
IP | 1 mg q.s. |
| 28 | Glimepiride Tablets IP | Each uncoated tablet contains: Glimepiride Excipients Approved Colour Used |
IP | 2 mg q.s. |
| 29 | Metformin Hydrochloride Prolonged- Release Tablets IP |
Each uncoated Prolonged- Release Tablet Contains: Metformin Hydrochloride Excipients |
IP |
100 mg |
| 30 | Metformin Hydrochloride Prolonged-Release Tablets IP |
Each uncoated Prolonged- Release Tablet Contains: Metformin Hydrochloride Excipients |
IP |
500 mg |
| 31 | Metformin Hydrochloride Prolonged-Release Tablets IP |
Each uncoated Prolonged- Release Tablet Contains: Metformin Hydrochloride Excipients |
IP |
850 mg |
| 32 | Metformin Hydrochloride Prolonged-Release Tablets IP |
Each uncoated Prolonged- Release Tablet Contains: Metformin Hydrochloride Excipients |
IP |
1000 mg |
| 33 | Sitagliptin Phosphate Tablets IP | Each film coated Tablet contains: Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used |
IP | 25 mg q.s. |
| 34 | Sitagliptin Phosphate Tablets IP | Each film coated Tablet contains: Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Excipients pproved Colour used |
IP | 50 mg q.s. |
| 35 | Sitagliptin Phosphate Tablets IP | Each film coated Tablet contains: Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used |
IP | 100 mg q.s. |
| 36 | Voglibose Tablets IP | Each uncoated tablet contains: Voglibose Excipients Approved Colour used |
IP | 0.2 mg |
| 37 | Voglibose Tablets IP | Each uncoated tablet contains: Voglibose Excipients Approved Colour used |
IP | 0.2 mg |
| 38 | Voglibose Dispersible Tablets IP | Each uncoated dispersible tablet contains: Voglibose Excipients Approved Colour used |
IP | 0.2 mg |
| 39 | Voglibose Dispersible Tablets IP | Each uncoated dispersible tablet contains: Voglibose Excipients Approved Colour used |
IP | 0.3 mg |
| 40 | Metformin Hydrochloride Prolonged-Release & Glimepiride Tablets IP | Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (As Prolonged Release) Excipients Approved colour used. |
IP IP |
1mg 500mg q.s. |
| 41 | Metformin Hydrochloride Prolonged-Release & Glimepiride Tablets IP | Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (As Prolonged Release) Excipients Approved colour used. |
IP IP |
2mg 500mg q.s. |
| 42 | Sildenafil Tablets IP | Each film coated Tablet contains: Sildenafil Citrate Equ. to Sildenafil Excipients Approved Colour used |
IP | 25 mg q.s. |
| 43 | Sildenafil Tablets IP | Each film coated Tablet contains: Sildenafil Citrate Equ. to Sildenafil Excipients Approved Colour used |
IP | 50 mg q.s. |
| 44 | Sildenafil Tablets IP | Each film coated Tablet contains: Sildenafil Citrate Equ. to Sildenafil Excipients Approved Colour used |
IP | 100 mg q.s. |
| 45 | Naproxen Tablets IP | Each uncoated tablet contains: Naproxen Excipients Approved Colour used |
IP | 250 mg q.s. |
| 46 | Naproxen Tablets IP | Each uncoated tablet contains: Naproxen Excipients Approved Colour used |
IP | 500 mg q.s. |
| 47 | Nifedipine Tablets IP | Each uncoated tablet contains: Nifedipine Excipients Approved Colour used |
IP | 5 mg q.s. |
| 48 | Nifedipine Tablets IP | Each uncoated tablet contains: Nifedipine Excipients Approved Colour used |
IP | 10 mg q.s. |
| 49 | Nifedipine Prolonged-release Tablets IP | Each Prolonged- Release film coated Tablet Contains: Nifedipine Excipients Approved Colour used |
IP |
10 mg |
| 50 | Nifedipine Prolonged-release Tablets IP | Each Prolonged- Release film coated Tablet Contains: Nifedipine Excipients Approved Colour used |
IP |
20 mg |
| 51 | Atenolol Tablets IP | Each uncoated tablet Contains: – Atenolol Excipients Approved colour used |
IP | 50 mg q.s. |
| 52 | Atenolol Tablets IP | Each uncoated tablet Contains: – Atenolol Excipients Approved colour used |
IP | 100 mg q.s. |
| 53 | Glimepiride Tablets IP | Each uncoated tablet contains: Glimepiride Excipients Approved Colour Used |
IP | 3 mg q.s. |
| 54 | Glimepiride Tablets IP | Each uncoated tablet contains: Glimepiride Excipients Approved Colour Used |
IP | 4 mg q.s. |
| 55 | Telmisartan | Each uncoated tablet contains: Temisartan Excipients Approved Colour Used |
IP | 20 mg q.s. |
| 56 | Telmisartan | Each uncoated tablet contains: Temisartan Excipients Approved Colour Used |
IP | 40 mg q.s. |
| 57 | Telmisartan | Each uncoated tablet contains: Temisartan Excipients Approved Colour Used |
IP | 80 mg q.s. |
| 58 | Telmisartan and Amlodipine Tablets IP | Each uncoated bilayered tablet contains: Telmisartan Amlodipine Besilate Equivalent to Amlodipine Excipients Approved Colour Used |
IP IP |
40 mg
5 mg |
| 59 | Telmisartan and Amlodipine Tablets IP | Each uncoated bilayered tablet contains: Telmisartan Amlodipine Besilate Equivalent to Amlodipine Excipients Approved Colour Used |
IP | 80 mg
10 mg |
| 60 | Losartan Tablets IP | Each film coated tablet contains: Losartan Potassium Excipients Approved Colour Used |
IP | 50 mg q.s. |
| 61 | Losartan Tablets IP | Each film coated tablet contains: Losartan Potassium Excipients Approved Colour Used |
IP | 50 mg q.s. |
| 62 | Losartan Tablets IP | Each film coated tablet contains: Losartan Potassium Excipients Approved Colour Used |
IP | 100 mg q.s. |
| 63 | Telmisartan and Hydrochlorothiazide Tablets IP | Each uncoated bilayered tablet contains: Telmisartan Hydrochlorothiazide Excipients Approved Colour Used |
IP IP |
40 mg 12.5 mg q.s. |
| 64 | Telmisartan and Hydrochlorothiazide Tablets IP | Each uncoated bilayered tablet contains: Telmisartan Hydrochlorothiazide Excipients Approved Colour Used |
IP | 80 mg 12.5 mg q.s. |
| 65 | Amlodipine Tablets IP | Each uncoated tablet contains: Amlodipine Besilate Equivalent to Amlodipine Excipients Approved Colour Used |
IP |
5 mg |
| 66 | Amlodipine Tablets IP | Each uncoated tablet contains: Amlodipine Besilate Equivalent to Amlodipine Excipients Approved Colour Used |
IP | 10 mg q.s. |
| 67 | Azithromycin Tablets IP | Each film coated tablet contains: Azithromycin (as dehydrate) Equivalent to Azithromycin Anhydrous Excipients Approved colour used |
IP |
250 mg |
| 68 | Azithromycin Tablets IP | Each film coated tablet contains: Azithromycin (as dehydrate) Equivalent to Azithromycin Anhydrous Excipients Approved colour used |
IP |
500 mg |
| 69 | Atorvastatin Tablets IP | Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used |
IP |
10 mg |
| 70 | Atorvastatin Tablets IP | Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used |
IP |
20 mg |
| 71 | Atorvastatin Tablets IP | Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used |
IP |
40 mg |
| 72 | Atorvastatin Tablets IP | Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used |
IP |
80 mg |
| 73 | Atorvastatin Tablets IP | Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used |
IP |
5 mg |
| 74 | Methylprednisolone Tablets IP | Each uncoated tablet contains: Methylprednisolone Excipients Approved Colour Used |
IP | 2 mg q.s. |
| 75 | Methylprednisolone Tablets IP | Each uncoated tablet contains: Methylprednisolone Excipients Approved Colour Used |
IP | 4 mg q.s. |
| 76 | Methylprednisolone Tablets IP | Each uncoated tablet contains: Methylprednisolone Excipients Approved Colour Used |
IP | 16 mg q.s. |
| 77 | Methylprednisolone Tablets IP | Each uncoated tablet contains: Methylprednisolone Excipients Approved Colour Used |
IP | 8 mg q.s. |
| 78 | Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP | Each uncoated tablet contains: Mefenamic Acid Dicyclomine Hydrochloride Excipients Approved Colour Used |
IP IP |
250 mg 10 mg q.s. |
| 79 | Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP | Each uncoated tablet contains: Mefenamic Acid Dicyclomine Hydrochloride Excipients Approved Colour Used |
IP IP |
250 mg 20 mg q.s. |
| 80 | Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP | Each uncoated tablet contains: Mefenamic Acid Dicyclomine Hydrochloride Excipients Approved Colour Used |
IP IP |
500 mg 10 mg q.s. |
| 81 | Levocetirizine Tablets IP | Each film coated tablet contains: Levocetirizine Dihydrochloride Excipients Approved Colour Used |
IP |
5 mg |
| 82 | Ketorolac Tromethamine Tablets IP | Each uncoated tablet contains: Ketorolac Tromethamine Excipients Approved Colour Used |
IP |
10 mg |
| 83 | Levodopa and Carbidopa Tablets IP | Each uncoated Prolonged release tablet contains: Levodopa Carbidopa (Anhydrous) Excipients Approved Colour Used |
IP |
100 mg |
| 84 | Levodopa and Carbidopa Tablets IP | Each uncoated Prolonged release tablet contains: Levodopa Carbidopa (Anhydrous) Excipients Approved Colour Used |
IP |
200 mg |
| 85 | Ramipril Tablets IP | Each uncoated tablet contains: Ramipril Excipients Approved Colour used |
IP | 1.25 mg q.s. |
| 86 | Ramipril Tablets IP | Each uncoated tablet contains: Ramipril Excipients Approved Colour used |
IP | 2.25 mg q.s. |
| 87 | Ramipril Tablets IP | Each uncoated tablet contains: Ramipril Excipients Approved Colour used |
IP | 5 mg q.s. |
| 88 | Ramipril Tablets IP | Each uncoated tablet contains: Ramipril Excipients Approved Colour used |
IP | 10 mg q.s. |
| 89 | Ramipril and Hydrochlorothiazide Tablets IP | Each uncoated tablet contains: Ramipril Hydrochlorothiazide Excipients Approved Colour used |
IP IP |
2.5 mg 12.5 mg q.s. |
| 90 | Ramipril and HydrochlorothiazideTablets IP | Each uncoated tablet contains: Ramipril Hydrochlorothiazide Excipients Approved Colour used |
IP IP |
5 mg 25 mg q.s. |
| 91 | Metoprolol Succinate Prolonged release Tablets IP | Each film coated prolonged release tablets contains: Metoprolol Succinate Equivalent to Metoprolol Tartrate Excipients Approved colour used. |
IP |
12.5 mg |
| 92 | Metoprolol Succinate Prolonged release Tablets IP | Each film coated prolonged release tablets contains: Metoprolol Succinate Equivalent to Metoprolol Tartrate Excipients Approved colour used. |
IP |
25 mg |
| 93 | Metoprolol Succinate Prolonged release Tablets IP | Each film coated prolonged release tablets contains: Metoprolol Succinate Equivalent to Metoprolol Tartrate Excipients Approved colour used. |
IP |
50 mg |
| 94 | Metoprolol Succinate Prolonged release Tablets IP | Each film coated prolonged release tablets contains: Metoprolol Succinate Equivalent to Metoprolol Tartrate Excipients Approved colour used. |
IP |
100 mg |
| 95 | Minoxidil Tablets IP | Each uncoated tablet contains: Minoxidil Excipients Approved Colour used |
IP | 2.5 mg q.s. |
| 96 | Minoxidil Tablets IP | Each uncoated tablet contains: Minoxidil Excipients Approved Colour used |
IP | 5 mg q.s. |
| 97 | Minoxidil Tablets IP | Each uncoated tablet contains: Minoxidil Excipients Approved Colour used |
IP | 10 mg q.s. |
| 98 | Ivermectin Tablets IP | Each uncoated tablet contains: Ivermectin Excipients Approved Colour used |
IP | 3 mg q.s. |
| 99 | Ivermectin Tablets IP | Each uncoated tablet contains: Ivermectin Excipients Approved Colour used |
IP | 6 mg q.s. |
| 100 | Ivermectin Tablets IP | Each uncoated tablet contains: Ivermectin Excipients Approved Colour used |
IP | 12 mg q.s. |
| 101 | Montelukast Sodium Tablets IP | Each film coated tablet contains: Montelukast Sodium Equivalent to Montelukast Excipients Approved Colour used |
IP |
5 mg |
| 102 | Montelukast Sodium Tablets IP | Each film coated tablet contains: Montelukast Sodium Equivalent to Montelukast Excipients Approved Colour used |
IP |
10 mg |
| 103 | Hydroxyzine Hydrochloride Tablets IP | Each film coated tablet Contains: – Hydroxyzine Hydrochloride Excipients Approved colour used |
IP | 10 mg q.s. |
| 104 | Hydroxyzine Hydrochloride Tablets IP | Each film coated tablet Contains: – Hydroxyzine Hydrochloride Excipients Approved colour used |
IP | 25 mg q.s. |
| 105 | Etodolac Tablets IP | Each film coated tablet contains: Etodolac Excipients Approved Colour Used |
IP | 200 mg q.s. |
| 106 | Etodolac Tablets IP | Each film coated tablet contains: Etodolac Excipients Approved Colour Used |
IP | 300 mg q.s. |
| 107 | Etodolac Tablets IP | Each film coated tablet contains: Etodolac Excipients Approved Colour Used |
IP | 400 mg q.s. |
| 108 | Cetirizine Hydrochloride Tablets IP | Each film coated tablet contains: Cetirizine Hydrochloride Excipients Approved Colour Used |
IP | 10 mg q.s. |
| 109 | Cetirizine Hydrochloride Tablets IP | Each film coated tablet contains: Cetirizine Hydrochloride Excipients Approved Colour Used |
IP | 20 mg q.s. |
| 110 | Clozapine Tablets IP | Each film coated tablet contains: Clozapine Excipients Approved Colour Used |
IP | 25 mg q.s. |
| 111 | Clozapine | Each film coated tablet contains: Clozapine Excipients Approved Colour Used |
IP | 50 mg q.s. |
| 112 | Clozapine | Each film coated tablet contains: Clozapine Excipients Approved Colour Used |
IP | 100 mg q.s. |
| 113 | Clozapine | Each film coated tablet contains: Clozapine Excipients Approved Colour Used |
IP | 200 mg q.s. |
| 114 | Mirtazapine Tablets IP | Each film coated tablet contains: Mirtazapine Excipients Approved Colour Used |
IP | 15 mg q.s. |
| 115 | Mirtazapine Tablets IP | Each film coated tablet contains: Mirtazapine Excipients Approved Colour Used |
IP | 30 mg q.s. |
| 116 | Mirtazapine Tablets IP | Each film coated tablet contains: Mirtazapine Excipients Approved Colour Used |
IP | 45 mg q.s. |
| 117 | Aripiprazole Tablets IP | Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used |
IP | 5 mg q.s. |
| 118 | Aripiprazole Tablets IP | Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used |
IP | 10 mg q.s. |
| 119 | Aripiprazole Tablets IP | Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used |
IP | 15 mg q.s. |
| 120 | Aripiprazole Tablets IP | Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used |
IP | 20 mg q.s. |
| 121 | Aripiprazole Tablets IP | Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used |
IP | 30 mg q.s. |
| 122 | Amitriptyline Hydrochloride Tablets IP | Each film coated tablet contains: Amitriptyline Hydrochloride Excipients Approved Colour Used |
IP | 10 mg q.s. |
| 123 | Amitriptyline Hydrochloride Tablets IP | Each film coated tablet contains: Amitriptyline Hydrochloride Excipients Approved Colour Used |
IP | 25 mg q.s. |
| 124 | Amitriptyline Hydrochloride Tablets IP | Each film coated tablet contains: Amitriptyline Hydrochloride Excipients Approved Colour Used |
IP | 50 mg q.s. |
| 125 | Clarithromycin Tablets IP | Each film coated tablet contains: Clarithromycin Excipients Approved colour used |
IP | 250 mg q.s. |
| 126 | Clarithromycin Tablets IP | Each film coated tablet contains: Clarithromycin Excipients Approved colour used |
IP | 500 mg q.s. |
| 127 | Ebastine Tablets IP | Each film coated tablet contains: Ebastine Excipients Approved colour used |
IP | 5 mg q.s. |
| 128 | Ebastine Tablets IP | Each film coated tablet contains: Ebastine Excipients Approved colour used |
IP | 10 mg q.s. |
| 129 | Ebastine Tablets IP | Each film coated tablet contains: Ebastine Excipients Approved colour used |
IP | 20 mg q.s. |
| 130 | Donepezil Hydrochloride Tablets IP | Each film coated tablet contains: Donepezil Hydrochloride Excipients Approved colour used |
IP | 5 mg q.s. |
| 131 | Donepezil Hydrochloride Tablets IP | Each film coated tablet contains: Donepezil Hydrochloride Excipients Approved colour used |
IP | 10 mg q.s. |
| 132 | Amisulpride Tablets IP | Each uncoated tablet contains: Amisulpride Excipients Approved colour used |
IP | 50 mg q.s. |
| 133 | Amisulpride Tablets IP | Each uncoated tablet contains: Amisulpride Excipients Approved colour used |
IP | 100 mg q.s. |
| 134 | Amisulpride Tablets IP | Each uncoated tablet contains: Amisulpride Excipients Approved colour used |
IP | 200 mg q.s. |
| 135 | Amisulpride Tablets IP | Each uncoated tablet contains: Amisulpride Excipients Approved colour used |
IP | 300 mg q.s. |
| 136 | Amisulpride Tablets IP | Each uncoated tablet contains: Amisulpride Excipients Approved colour used |
IP | 400 mg q.s. |
| 137 | Risperidone Tablets IP | Each film coated tablet contains: Risperidone Excipients Approved colour used |
IP | 1 mg q.s. |
| 138 | Risperidone Tablets IP | Each film coated tablet contains: Risperidone Excipients Approved colour used |
IP | 2 mg q.s. |
| 139 | Risperidone Tablets IP | Each film coated tablet contains: Risperidone Excipients Approved colour used |
IP | 3 mg q.s. |
| 140 | Risperidone Tablets IP | Each film coated tablet contains: Risperidone Excipients Approved colour used |
IP | 4 mg q.s. |
| 141 | Lithium Carbonate Tablets IP | Each uncoated tablet contains: Lithium Carbonate Excipients Approved Colour Used |
IP | 300 mg q.s. |
| 142 | Olanzapine Tablets IP | Each film coated tablet contains: Olanzapine Excipients Approved Colour Used |
IP | 2.5 mg q.s. |
| 143 | Olanzapine Tablets IP | Each film coated tablet contains: Olanzapine Excipients Approved Colour Used |
IP | 5 mg q.s. |
| 144 | Olanzapine Tablets IP | Each film coated tablet contains: Olanzapine Excipients Approved Colour Used |
IP | 7.5 mg q.s. |
| 145 | Olanzapine Tablets IP | Each film coated tablet contains: Olanzapine Excipients Approved Colour Used |
IP | 10 mg q.s. |
| 146 | Olanzapine and Fluoxetine Tablets IP | Each film coated tablet contains: Olanzapine Fluoxetine Hydrochloride Equivalent to Fluoxetine Excipients Approved Colour Used |
IP IP |
5 mg
20 mg |
| 147 | Olanzapine and Fluoxetine Tablets IP | Each film coated tablet contains: Olanzapine Fluoxetine Hydrochloride Equivalent to Fluoxetine Excipients Approved Colour Used |
IP IP |
10 mg
20 mg |
| 148 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: Ursodeoxycholic acid Excipients Approved Colour Used |
IP | 150 mg q.s. |
| 149 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: Ursodeoxycholic acid Excipients Approved Colour Used |
IP | 300 mg q.s. |
| 150 | Ofloxacin and Ornidazole Tablets IP | Each film coated tablet contains: Ofloxacin Ornidazole Excipients Approved Colour used |
IP IP |
200 mg 500 mg q.s. |
| 151 | Venlafaxine Hydrochloride Tablets IP | Each film coated tablet contains: Venlafaxine Hydrochloride Equivalent to Venlafaxine Excipients Approved Colour used |
IP |
25 mg |
| 152 | Venlafaxine Hydrochloride Tablets IP | Each film coated tablet contains: Venlafaxine Hydrochloride Equivalent to Venlafaxine Excipients Approved Colour used |
IP |
37.5 mg |
| 153 | Venlafaxine Hydrochloride Tablets IP | Each film coated tablet contains: Venlafaxine Hydrochloride Equivalent to Venlafaxine Excipients Approved Colour used |
IP |
75 mg |
| 154 | Clomipramine Hydrochloride Capsules IP | Each hard gelatin capsule contains: Clomipramine Hydrochloride Excipients Approved Colour used in empty capsule shells. |
IP | 25 mg q.s. |
| 155 | Clomipramine Hydrochloride Capsules IP | Each hard gelatin capsule contains: Clomipramine Hydrochloride Excipients Approved Colour used in empty capsule shells. |
IP | 75 mg q.s. |
| 156 | Clomipramine Hydrochloride Capsules IP | Each hard gelatin capsule contains: Clomipramine Hydrochloride Excipients Approved Colour used in empty capsule shells. |
IP | 100 mg q.s. |
| 157 | Itraconazole Capsules IP | Each capsule contains: Excipients Approved Colour used in empty capsule shells. |
IP | 100 mg q.s. |
| 158 | Duloxetine Gastro-Resistant Tablets IP | Each gastro-resistant tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients Approved Colour used |
IP | 20 mg q.s. |
| 159 | Duloxetine Gastro-Resistant Tablets IP | Each gastro-resistant tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients Approved Colour used |
IP | 30 mg q.s. |
| 160 | Duloxetine Gastro-Resistant Tablets IP | Each gastro-resistant tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients Approved Colour used |
IP | 40 mg q.s. |
| 161 | Duloxetine Gastro-Resistant Tablets IP | Each gastro-resistant tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients Approved Colour used |
IP | 60 mg q.s. |
| 162 | Fluvoxamine Tablets IP | Each film coated tablet contains: Fluvoxamine maleate Excipients Approved Colour used |
IP | 25 mg q.s. |
| 163 | Fluvoxamine Tablets IP | Each film coated tablet contains: Fluvoxamine maleate Excipients Approved Colour used |
IP | 50 mg q.s. |
| 164 | Fluvoxamine Tablets IP | Each film coated tablet contains: Fluvoxamine maleate Excipients Approved Colour used |
IP | 100 mg q.s. |
| 165 | Quetiapine Tablets IP | Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved Colour used |
IP |
25 mg |
| 166 | Quetiapine Tablets IP | Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved Colour used |
IP |
50 mg |
| 167 | Quetiapine Tablets IP | Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved Colour used |
IP |
100 mg |
| 168 | Quetiapine Tablets IP | Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved Colour used |
IP |
200 mg |
| 169 | Imipramine Hydrochloride Tablets IP | Each film coated tablet contains: Imipramine Hydrochloride Excipients Approved Colour used |
IP | 10 mg q.s. |
| 170 | Imipramine Hydrochloride Tablets IP | Each film coated tablet contains: Imipramine Hydrochloride Excipients Approved Colour used |
IP | 25 mg q.s. |
| 171 | Escitalopram Tablets IP | Each film coated tablet contains: Escitalopram Oxalate Eq. to Escitalopram Excipients Approved Colour used |
IP |
5 mg |
| 172 | Escitalopram Tablets IP | Each film coated tablet contains: Escitalopram Oxalate Eq. to Escitalopram Excipients Approved Colour used |
IP |
10 mg |
| 173 | Escitalopram Tablets IP | Each film coated tablet contains: Escitalopram Oxalate Eq. to Escitalopram Excipients Approved Colour used |
IP |
20 mg |
| 174 | Paroxetine Tablets IP | Each film coated tablet contains: Paroxetine Hydrochloride Hemihydratev Eq. to Paroxetine Excipients |
IP |
10 mg |
| 175 | Paroxetine Tablets IP | Each film coated tablet contains: Paroxetine Hydrochloride Hemihydrate Eq. to Paroxetine Excipients |
IP |
20 mg |
| 176 | Paroxetine Tablets IP | Each film coated tablet contains: Paroxetine Hydrochloride Hemihydrate Eq. to Paroxetine Excipients |
IP |
30 mg |
| 177 | Paroxetine Tablets IP | Each film coated tablet contains: Paroxetine Hydrochloride Hemihydrate Eq. to Paroxetine Excipients |
IP |
40 mg |
| 178 | Sertraline Tablets IP | Each film coated tablet contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved Colour used |
IP |
25 mg |
| 179 | Sertraline Tablets IP | Each film coated tablet contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved Colour used |
IP |
50 mg |
| 180 | Sertraline Tablets IP | Each film coated tablet contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved Colour used |
IP |
100 mg |
| 181 | Fluoxetine Capsules IP | Each hard gelatin capsule contains: Fluoxetine Hydrochloride Eq. to Fluoxetine Excipients Approved Colour used in empty capsule shells. |
IP |
10 mg |
| 182 | Fluoxetine Capsules IP | Each hard gelatin capsule contains: Fluoxetine Hydrochloride Eq. to Fluoxetine Excipients Approved Colour used in empty capsule shells. |
IP |
20 mg |
| 183 | Fluoxetine Capsules IP | Each hard gelatin capsule contains: Fluoxetine Hydrochloride Eq. to Fluoxetine Excipients Approved Colour used in empty capsule shells. |
IP |
60 mg |
| 184 | Fluoxetine Tablets IP | Each film coated tablet contains: Fluoxetine Hydrochloride Eq. to Fluoxetine Excipients Approved Colour used |
IP |
10 mg |
| 185 | Fluoxetine Tablets IP | Each film coated tablet contains: Fluoxetine Hydrochloride Eq. to Fluoxetine Excipients Approved Colour used |
IP |
20 mg |
| 186 | Topiramate Tablets IP | Each film coated tablet contains: Topiramate Excipients Approved Colour used |
IP | 25 mg q.s. |
| 187 | Topiramate Tablets IP | Each film coated tablet contains: Topiramate Excipients Approved Colour used |
IP | 50 mg q.s. |
| 188 | Topiramate Tablets IP | Each film coated tablet contains: Topiramate Excipients Approved Colour used |
IP | 100 mg q.s. |
| 189 | Topiramate Tablets IP | Each film coated tablet contains: Topiramate Excipients Approved Colour used |
IP | 200 mg q.s. |
| 190 | Topiramate Tablets IP | Each film coated tablet contains: Topiramate Excipients Approved Colour used |
IP | 300 mg q.s. |
| 191 | Topiramate Tablets IP | Each film coated tablet contains: Topiramate Excipients Approved Colour used |
IP | 400 mg q.s. |
| 192 | Dosulepin Tablets IP | Each film coated tablet contains: Dosulepin Hydrochloride Excipients Approved Colour used |
IP | 25 mg q.s. |
| 193 | Dosulepin Tablets IP | Each film coated tablet contains: Dosulepin Hydrochloride Excipients Approved Colour used |
IP | 50 mg q.s. |
| 194 | Dosulepin Tablets IP | Each film coated tablet contains: Dosulepin Hydrochloride Excipients Approved Colour used |
IP | 75 mg q.s. |
| 195 | Pantoprazole Sodium (Enteric coated) & Domperidone(Sustained Release)Capsules IP | Each hard gelatin capsule contains: – Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As Enteric Coated Pellets) Domperidone (As Sustained Release Pellets) Excipients Approved colour used in empty capsule shells. |
IP
IP |
30 mg
40 mg |
| 196 | Omeprazole (Enteric Coated) & Domperidone Capsules IP | Each hard gelatin capsule contains: – Omeprazole (As Enteric Coated Pellets) Domperidone Excipients Approved colour used in empty capsule shells. |
IP
IP |
20 mg
10 mg |
| 197 | Rabeprazole Sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules | Each hard gelatin capsule contains: – Rabeprazole Sodium (As Enteric Coated Pellets) Domperidone (As Sustained Release Pellets) Excipients Approved colour used in empty capsule shells. |
IP IP |
20 mg 30 mg q.s. |
| 198 | Omeprazole Capsules IP | Each hard gelatin capsule contains: – Omeprazole (As Enteric Coated Pellets) Excipients Approved colour used in empty capsule shells. |
IP | 20 mg q.s. |
| 199 | Rabeprazole Sodium (Enteric Coated) & Levosulpiride (Sustained Release) Capsules | Each hard gelatin capsule contains: – Rabeprazole Sodium (As Enteric Coated Pellets) Levosulpiride (As Sustained Release Pellets) Excipients Approved colour used in empty capsule shells. |
IP
IH |
20 mg
75 mg |
| 200 | Rabeprazole Sodium (Enteric Coated) & Itopride Hydrochloride (Sustained Release) Capsules | Each hard gelatin capsule contains: – Rabeprazole Sodium (As Enteric Coated Pellets) Levosulpiride (As Sustained Release Pellets) Excipients Approved colour used in empty capsule shells. |
IP
IP |
20 mg 150 mg |
| 201 | Esomeprazole (Enteric Coated) & Domperidone Sustained Release Capsules | Each hard gelatin capsule contains: – Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole (As Enteric Coated Pellets) Domperidone (As Sustained Release Pellets) Excipients Approved colour used in empty capsule shells. |
IP
IP |
40 mg 30 mg |
| 202 | Pantoprazole Sodium & Domperidone Tablets | Each hard gelatin capsule contains: – Pantoprazole Sodium Eq. to Pantoprazole Domperidone Excipients Colour:-Approved colour used. |
IP
IP |
40 mg 10 mg |
| 203 | Nimesulide Tablets IP | Each uncoated tablet contains: – Nimesulide Excipients Colour:-Approved colour used. |
BP | 100 mg q.s. |
| 204 | Paracetamol Tablets IP | Each uncoated tablet contains: – Paracetamol Excipients Colour:-Approved colour used. |
IP | 650 mg q.s. |
| 205 | Deflazacort Tablets | Each uncoated tablet contains: – Deflazacort Excipients Colour:-Approved colour used. |
6 mg q.s. |
|
| 206 | Pantoprazole Gastro-Resistant Tablets IP | Each enteric coated tablet contains: – Pantoprazole Sodium Eq. to Pantoprazole Excipients Colour: -Approved colour used. |
IP |
40 mg |
| 207 | Ofloxacin Tablets IP | Each film coated tablet contains: – Ofloxacin Excipients Colour: -Approved colour used. |
IP | 200 mg q.s. |
| 208 | Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP | Each film coated tablet contains: – Montelukast Sodium Eq. to Montelukast Levocetirizine Dihydrochloride Excipients Colour: -Approved colour used. |
IP
IP |
10 mg |
| 209 | Aceclofenac & Paracetamol Tablets IP | Each film coated tablet contains: – Aceclofenac Paracetamol Excipients Colour:-Approved colour used. |
IP IP |
100 mg 325 mg q.s. |
| 210 | Febuxostat Tablets | Each film coated tablet contains: – Febuxostat Excipients Colour: -Approved colour used. |
40 mg q.s. |
|
| 211 | Paracetamol Tablets IP |
Each uncoated tablet contains: – Paracetamol Excipients Colour:-Approved colour used. |
IP | 500 mg q.s. |
